Methylpred is a medicine containing the active ingredient(s) methylprednisolone. On this page you will find out more about Methylpred, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: methylprednisolone
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Methylpred 500 mg powder for injection, 1 vial
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
When oral therapy is not feasible & strength, dosage form & route of administration of drug reasonably lend preparation to treatment of following conditions. Intravenous or intramuscular use only.,Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is drug of choice; synthetic analogues may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). Acute adrenocortical insufficiency (hydrocortisone or cortisone is drug of choice; mineralocorticoid supplementation may be necessary particularly when synthetic analogues are used). Preoperatively & in event of serious trauma or illness in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. Shock unresponsive to conventional therapy if adrenocortical insufficiency exists or suspected, congenital adrenal hyperplasia, nonsuppurative thyroiditis, hypercalcaemia associated with cancer. Congenital adrenal hyperplasia. Nonsuppurative thyroiditis. Hypercalcaemia associated with cancer.,Rheumatic disorders: Adjunctive therapy for short-term administration (to tide patient over an acute episode or exacerbation) in ankylosing spondylitis, psoriatic arthritis, acute & subacute bursitis, synovitis of osteoarthritis, acute non-specific tenosynovitis, epicondylitis, acute gouty arthritis, post-traumatic osteoarthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low dose maintenance therapy).,Collagen disease: During exacerbation or maintenance therapy in selected cases of systemic lupus erythematosus, systemic dermatomyositis (polymyositis), acute rheumatic carditis.,Dermatological diseases: Bullous dermatitis herpetiformis, severe psoriasis, severe seborrhoeic dermatitis, exfoliative dermatitis, pemphigus, mycosis fungoides, severe erythema multiforme (Stevens Johnson syndrome).,Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in bronchial asthma, drug hypersensitivity reactions, contact dermatitis, urticarial transfusion reactions, atopic dermatitis, serum sickness, seasonal or perennial allergic rhinitis, acute non-infectious laryngeal oedema (adrenaline is drug of first choice).,Ophthalmic diseases: Severe acute & chronic allergic & inflammatory processes involving eye, such as allergic corneal marginal ulcers, , allergic conjunctivitis, chorioretinitis, anterior segment inflammation, herpes zoster ophthalmicus, iritis iridocvclitis, diffuse posterior uveitis & choroiditis, keratitis, optic neuritis, sympathetic ophthalmia.,Gastrointestinal diseases: To tide patient over a critical period of disease in ulcerative colitis (systemic therapy), regional enteritis (systemic therapy).,Respiratory diseases: Symptomatic sarcoidosis, berylliosis, aspiration pneumonitis, Loeffler's syndrome not manageable by other means, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy.,Haematologic disorders: Idiopathic thrombocytopenic purpura in adults (intravenous only; intramuscular is contraindicated), secondary thrombocytopenia in adults, acquired (autoimmune) haemolytic anaemia, erythroblastopenia (red blood cell anaemia), congenital (erythroid) hypoplastic anaemia.,Neoplastic diseases: Palliative management of leukaemias & lymphomas in adults, acute leukaemia of childhood.,Oedematous states: To induce diuresis or remission of proteinuria in nephrotic syndrome, without uraemia, of idiopathic type or due to lupus erythematosus.,Nervous system: Acute exacerbations of multiple sclerosis.,Miscellaneous: Tuberculous meningitis with subarachnoid or impending block when used concurrently with appropriate antituberculous chemotherapy. Trichinosis with neurological or myocardial involvement. METHYLPRED is beneficial as adjunctive therapy in treatment of AIDS affected patients with moderate to severe P. carinii pneumonia when given within first 72hrs of initial antipneumocystis treatment.
Table of characteristics
|Visual appearance||White to off white lyophilised plug or powder|
|Dosage Form||Injection, powder for|
|Route of administration||Intravenous|
1's: Prescription Only Medicine, or Prescription Animal Remedy
5's: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||Protect from Light|
|Life time||2 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.